Clinical Trial Update: Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of M100907 for sleep maintenance insomnia, including a sub-study in individuals with stable type 2 diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Type 2 Diabetes Mellitus

Drugs mentioned

• M100907 (MDL-100,907)

Snippet

Sponsor: Sanofi | Conditions: Sleep Initiation and Maintenance Disorders | Phase 3 | Status: COMPLETED